Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.

Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A
Kidney Int. 1997 51 (1): 164-72

PMID: 8995730 · DOI:10.1038/ki.1997.20

We examined the potential of in vivo linkage of plasminogen activator inhibitor-1 (PAI-1) and angiotensin II (Ang II) in the setting of endothelial injury and sclerosis following radiation injury in the rat. PAI-1 is a major physiological inhibitor of the plasminogen activator (PA)/plasmin system, a key regulator of fibrinolysis and extracellular matrix (ECM) turnover. PAI-1 mRNA expression in the kidney was markedly increased (9-fold) at 12 weeks after irradiation (P < 1.001 vs. normal control). In situ hybridization revealed significant association of PAI-1 expression with sites of glomerular injury (signal intensity in injured vs. intact glomeruli, P < 0.001). Angiotensin converting enzyme inhibitors (ACEI, captopril or enalapril) or angiotensin II receptor antagonist (AIIRA, L158,809) markedly reduced glomerular lesions (thrombosis, mesangiolysis, and sclerosis; sclerosis index, 0 to 4+ scale, 0.49 +/- 0.20 in untreated vs. 0.05 +/- 0.02, 0.02 +/- 0.01, 0.04 +/- 0.02 in captopril, enalapril and AIIRA, respectively, all P < 0.01 vs untreated). Further, ACEI and AIIRA markedly attenuated increased PAI-1 mRNA expression in the irradiated kidney (36, 19 and 20% expression, respectively, for captopril, enalapril and AIIRA, compared to untreated irradiated kidney, P < 0.05, < 0.01, < 0.01). This effect was selective in that neither tissue-type nor urokinase-type PA mRNA expression was affected by these interventions. Thus, we speculate that inhibition of the renin-angiotensin system may ameliorate injury following radiation by accelerating fibrinolysis and ECM degradation, at least in part, via suppression of PAI-1 expression. In summary, inhibition of Ang II, in addition to its known effects on vascular sclerosis, may also by its novel effect to inhibit PAI-1, lessen fibrosis following endothelial/thrombotic injury.

MeSH Terms (29)

Angiotensin-Converting Enzyme Inhibitors Angiotensin II Angiotensin Receptor Antagonists Animals Antihypertensive Agents Captopril Cytokines Enalapril Fibrin Fibrinolysin Fibrosis Gene Expression Regulation, Enzymologic Growth Substances Imidazoles In Situ Hybridization Kidney Male Plasminogen Activator Inhibitor 1 Proteinuria Rats Rats, Sprague-Dawley Renal Circulation Renin RNA, Messenger Tetrazoles Thrombosis Tissue Plasminogen Activator Urokinase-Type Plasminogen Activator Vasoconstrictor Agents

Connections (2)

This publication is referenced by other Labnodes entities: